Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit

Código QR

Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiahui Zhang, Heng Liu, Hong Jiang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	Parkinson’s disease substantia nigra motor function α-synuclein nigrostriatal circuit Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/880b32d65a684622b1ee418327c4651b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Frank Y. Shan, et al.
Publicado: (2021)

Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson’s Disease: A Diffusion Tensor Imaging Study
por: Niels Bergsland, et al.
Publicado: (2021)

Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease
por: Vieira de Moraes Filho A, et al.
Publicado: (2020)

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Lea Elsholz, et al.
Publicado: (2021)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
por: Ruichen Su, et al.
Publicado: (2021)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021)

The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease
por: Sheelu Monga, et al.
Publicado: (2021)

Dopamine Circuit Mechanisms of Addiction-Like Behaviors
por: Carli L. Poisson, et al.
Publicado: (2021)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
por: Charlotte F. Brzozowski, et al.
Publicado: (2021)

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
por: Eva Nordström, et al.
Publicado: (2021)

Asymmetry in Parkinson’s disease and its relationship with strength
por: Sacha Clael, et al.
Publicado: (2021)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Kuo-Hsuan Chang, et al.
Publicado: (2021)

Effects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells
por: Emma Lorentzon, et al.
Publicado: (2021)

(De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants
por: Joana Angélica Loureiro, et al.
Publicado: (2021)

Altered Development of Mesencephalic Dopaminergic Neurons in SIDS: New Insights into Understanding Sudden Infant Death Pathogenesis
por: Anna Maria Lavezzi
Publicado: (2021)

Is Generalized and Segmental Dystonia Accompanied by Impairments in the Dopaminergic System?
por: Jun Ikezawa, et al.
Publicado: (2021)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)

Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro
por: Masatoshi Inden, et al.
Publicado: (2021)

Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
por: Alimohammadi E, et al.
Publicado: (2020)

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

COMPARISON EFFECT BETWEEN PEGAGAN (Centella asiatica) EXTRACT AND PRAMIPEXOLE TOWARD LOCOMOTOR ACTIVITIES, α - SYNUCLEIN, AND NRF2 EXPRESSION IN ZEBRAFISH PARKINSON MODEL
por: Ayu Trisnawati, et al.
Publicado: (2019)

Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, <i>PINK1</i> and <i>PARK9</i>
por: Anastasiia Bohush, et al.
Publicado: (2021)

Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor
por: Mohammadi S, et al.
Publicado: (2017)

Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation
por: Stefania Vogiatzis, et al.
Publicado: (2021)

α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency
por: Tahaei Gilan SS, et al.
Publicado: (2019)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Jennifer A. Macdonald, et al.
Publicado: (2021)

Missense Mutations Modify the Conformational Ensemble of the α-Synuclein Monomer Which Exhibits a Two-Phase Characteristic
por: Adrien Guzzo, et al.
Publicado: (2021)

Dendritic Architecture Predicts in vivo Firing Pattern in Mouse Ventral Tegmental Area and Substantia Nigra Dopaminergic Neurons
por: Trinidad Montero, et al.
Publicado: (2021)

Association between Sleep, Alzheimer’s, and Parkinson’s Disease
por: Sumire Matsumoto, et al.
Publicado: (2021)

Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in <i>Drosophila</i>
por: Jean-Noël Arsac, et al.
Publicado: (2021)

Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
por: Resnikoff H, et al.
Publicado: (2019)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
por: Arianna Sala, et al.
Publicado: (2021)

Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
por: Elena Diekämper, et al.
Publicado: (2021)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Marco J. Russo, et al.
Publicado: (2021)

The Bacterial Amyloids Phenol Soluble Modulins from <i>Staphylococcus aureus</i> Catalyze Alpha-Synuclein Aggregation
por: Caroline Haikal, et al.
Publicado: (2021)

Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein
por: Judit Oláh, et al.
Publicado: (2021)

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Anastazja M. Gorecki, et al.
Publicado: (2021)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
por: Rongfang Que, et al.
Publicado: (2021)